Weight-loss drugs such as Ozempic and Mounjaro are reshaping beauty standards in ways that may threaten long-standing Black beauty ideals, raising uncomfortable questions about cultural identity, class aspiration and the…
Author: Sophie Hargreaves
Sophie Hargreaves
Health Correspondent
Sophie Hargreaves covers medical research, new treatments, disease outbreaks and prevention for Health News Daily. She holds a Master's degree in Health Sciences from the University of Leeds and has spent several years translating complex medical science into clear, accessible reporting for a general audience. Sophie focuses on the latest clinical trials, NICE and MHRA approvals, vaccination programmes and emerging health threats, always with an eye on what these developments mean for people in the UK.
· MSc Health Sciences (University of Leeds), science communication volunteer, medical research literacy
· Clinical trials and drug approvals (NICE, MHRA), cancer screening programmes, vaccination and outbreak response, women's health (endometriosis, PCOS, menopause), weight management treatments, AI in diagnostics
Prostate cancer patients in England are set to benefit from a major expansion of a cutting-edge radiotherapy technique that will slash the number of hospital visits they need to undergo.The…
A new daily pill has helped people lose more than 10 per cent of their body weight within six months, according to the results of two Phase II trials published…
Hospitalisations for heat-related illnesses in the United States could double over the next 15 years, new research warns, as rising temperatures driven by climate change collide with deepening economic inequality…
Quarantines are in place across four Texas counties due to a flesh-eating parasite, with authorities scrambling to contain an outbreak that has already spread into neighbouring New Mexico.The Texas Animal…
Veteran broadcaster Jon Snow’s decision to publicly disclose his Alzheimer’s diagnosis has triggered a sharp spike in traffic to the Alzheimer’s Society website, with thousands of visitors seeking information on…
Nearly $10 million (£7.5m) worth of American-made contraceptives, including birth control pills, intrauterine devices and hormonal implants, are sitting in a warehouse in Belgium, approaching their expiry dates while the…
Artificial intelligence is saving clinicians an average of 132 hours each year — the equivalent of more than three full working weeks — yet a chronic lack of training is…
A new cancer vaccine trial targeting bowel and ovarian cancer in at-risk individuals is set to begin this summer, with the first patients expected to receive an experimental mRNA jab…
A new drug may preserve muscle mass during weight loss, according to early-stage research that raises the prospect of a more complete approach to slimming treatments. The study, published in…